<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04550806</url>
  </required_header>
  <id_info>
    <org_study_id>ZS-1703</org_study_id>
    <nct_id>NCT04550806</nct_id>
  </id_info>
  <brief_title>Glycated Albumin Combined With Body Composition for Gestational Diabetes Mellitus Prediction</brief_title>
  <official_title>The Predictive Ability of Glycated Albumin Combined With Body Composition for Gestational Diabetes Mellitus Diagnosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is going to investigate the predictive ability of glycated albumin combined with&#xD;
      body composition, including body weight, BMI, fat free mass and fat mass for gestational&#xD;
      diabetes mellitus (GDM) diagnosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence of GDM is increasing all over the world. It has bad influence for both&#xD;
      pregnant women and fetus. Early treatment is useful for GDM prevention. Therefore early&#xD;
      screening is important for healthcare doctors to detect the potential patients. Glycated&#xD;
      albumin (GA) is an optimal index for blood glucose evaluation compared to HbA1c, however it&#xD;
      may be influenced by body weight and composition. The investigators are going to investigate&#xD;
      the predictive ability of glycated albumin combined with body composition, including body&#xD;
      weight, BMI, fat free mass and fat mass for gestational diabetes mellitus (GDM) diagnosis.&#xD;
      This study recruit pregnant women before 12 weeks of their pregnant age and test GA level and&#xD;
      body composition via bioelectrical impedance analysis. During 24-28 weeks of pregnant age,&#xD;
      all participants will do the glucose tolerant test for GDM diagnosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the curve of GA combined with body composition for GDM diagnosis</measure>
    <time_frame>May 2021</time_frame>
    <description>prediction ability of GA and body compostion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlative factors for GDM</measure>
    <time_frame>May 2021</time_frame>
    <description>regression model to detect correlative factors for GDM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GDM prediction model establishment</measure>
    <time_frame>May 2021</time_frame>
    <description>multiple regression model to establish screening system for GDM</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Gestational Diabetes Mellitus in Pregnancy</condition>
  <arm_group>
    <arm_group_label>GDM</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non-GDM</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        pregnant women at first trimester&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 20-45&#xD;
&#xD;
          -  Healthy, without heart disease, liver or kidney dysfunction, immune system or&#xD;
             metabolic or infectious disease,&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetes that appeared before pregnancy&#xD;
&#xD;
          -  Pregnant with medical disease, such as asthma, hypertension, cardiovascular diseases,&#xD;
             kidney diseases or liver disease.&#xD;
&#xD;
          -  Hormone use in the recent 1 year&#xD;
&#xD;
          -  Assisted reproduction pregnancy&#xD;
&#xD;
          -  Multiple births&#xD;
&#xD;
          -  Cannot complete the blood test or body composition examination&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kang Yu, MD</last_name>
    <role>Study Director</role>
    <affiliation>Clinical nutrition department of Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kang Yu, MD</last_name>
    <phone>+8613801130457</phone>
    <email>yuk1997@sina.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fang Wang, MD</last_name>
    <phone>+8615201646084</phone>
    <email>yours.fang@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kang Yu, MD, PHD</last_name>
      <phone>+8613801130457</phone>
      <email>yuk1997@sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Fang Wang, MD, MS</last_name>
      <phone>+8615201646084</phone>
      <email>yours.fang@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 9, 2020</study_first_submitted>
  <study_first_submitted_qc>September 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>October 16, 2020</last_update_submitted>
  <last_update_submitted_qc>October 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Pregnancy in Diabetics</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>we can update the information collected of this study</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

